Singh2006_TCA_mtu_model1

  public model
Short description

This a model from the article:
Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets.
Singh VK , Ghosh I Theor Biol Med Model 2006 Aug 3;3:27 16887020 ,
Abstract:
BACKGROUND: Targeting persistent tubercule bacilli has become an important challenge in the development of anti-tuberculous drugs. As the glyoxylate bypass is essential for persistent bacilli, interference with it holds the potential for designing new antibacterial drugs. We have developed kinetic models of the tricarboxylic acid cycle and glyoxylate bypass in Escherichia coli and Mycobacterium tuberculosis, and studied the effects of inhibition of various enzymes in the M. tuberculosis model. RESULTS: We used E. coli to validate the pathway-modeling protocol and showed that changes in metabolic flux can be estimated from gene expression data. The M. tuberculosis model reproduced the observation that deletion of one of the two isocitrate lyase genes has little effect on bacterial growth in macrophages, but deletion of both genes leads to the elimination of the bacilli from the lungs. It also substantiated the inhibition of isocitrate lyases by 3-nitropropionate. On the basis of our simulation studies, we propose that: (i) fractional inactivation of both isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 is required for a flux through the glyoxylate bypass in persistent mycobacteria; and (ii) increasing the amount of active isocitrate dehydrogenases can stop the flux through the glyoxylate bypass, so the kinase that inactivates isocitrate dehydrogenase 1 and/or the proposed inactivator of isocitrate dehydrogenase 2 is a potential target for drugs against persistent mycobacteria. In addition, competitive inhibition of isocitrate lyases along with a reduction in the inactivation of isocitrate dehydrogenases appears to be a feasible strategy for targeting persistent mycobacteria. CONCLUSION: We used kinetic modeling of biochemical pathways to assess various potential anti-tuberculous drug targets that interfere with the glyoxylate bypass flux, and indicated the type of inhibition needed to eliminate the pathogen. The advantage of such an approach to the assessment of drug targets is that it facilitates the study of systemic effect(s) of the modulation of the target enzyme(s) in the cellular environment.

This model originates from BioModels Database: A Database of Annotated Published Models (http://www.ebi.ac.uk/biomodels/). It is copyright (c) 2005-2010 The BioModels.net Team.
For more information see the terms of use .
To cite BioModels Database, please use: Li C, Donizelli M, Rodriguez N, Dharuri H, Endler L, Chelliah V, Li L, He E, Henry A, Stefan MI, Snoep JL, Hucka M, Le Novère N, Laibe C (2010) BioModels Database: An enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol., 4:92.

Format
SBML (L2V4)
Related Publication
  • Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets.
  • Singh VK, Ghosh I
  • Theoretical biology & medical modelling , 0/ 2006 , Volume 3 , pages: 27
  • Bioinformatics Centre, University of Pune, Pune-411007, India. vivek@bioinfo.ernet.in
  • BACKGROUND: Targeting persistent tubercule bacilli has become an important challenge in the development of anti-tuberculous drugs. As the glyoxylate bypass is essential for persistent bacilli, interference with it holds the potential for designing new antibacterial drugs. We have developed kinetic models of the tricarboxylic acid cycle and glyoxylate bypass in Escherichia coli and Mycobacterium tuberculosis, and studied the effects of inhibition of various enzymes in the M. tuberculosis model. RESULTS: We used E. coli to validate the pathway-modeling protocol and showed that changes in metabolic flux can be estimated from gene expression data. The M. tuberculosis model reproduced the observation that deletion of one of the two isocitrate lyase genes has little effect on bacterial growth in macrophages, but deletion of both genes leads to the elimination of the bacilli from the lungs. It also substantiated the inhibition of isocitrate lyases by 3-nitropropionate. On the basis of our simulation studies, we propose that: (i) fractional inactivation of both isocitrate dehydrogenase 1 and isocitrate dehydrogenase 2 is required for a flux through the glyoxylate bypass in persistent mycobacteria; and (ii) increasing the amount of active isocitrate dehydrogenases can stop the flux through the glyoxylate bypass, so the kinase that inactivates isocitrate dehydrogenase 1 and/or the proposed inactivator of isocitrate dehydrogenase 2 is a potential target for drugs against persistent mycobacteria. In addition, competitive inhibition of isocitrate lyases along with a reduction in the inactivation of isocitrate dehydrogenases appears to be a feasible strategy for targeting persistent mycobacteria. CONCLUSION: We used kinetic modeling of biochemical pathways to assess various potential anti-tuberculous drug targets that interfere with the glyoxylate bypass flux, and indicated the type of inhibition needed to eliminate the pathogen. The advantage of such an approach to the assessment of drug targets is that it facilitates the study of systemic effect(s) of the modulation of the target enzyme(s) in the cellular environment.
Contributors
Indira Ghosh

Metadata information

is
BioModels Database MODEL8584292730
BioModels Database BIOMD0000000219
isDescribedBy
PubMed 16887020
hasVersion
Gene Ontology GO:0006099
Gene Ontology GO:0006097
isHomologTo
isVersionOf
Curation status
Curated
Name Description Size Actions

Model file

BIOMD0000000219_url.xml SBML L2V4 representation of Singh2006_TCA_mtu_model1 60.66 KB Preview | Download

Additional files

BIOMD0000000219_manual.svg Manually generated Reaction graph (SVG) 34.68 KB Preview | Download
BIOMD0000000219.m Auto-generated Octave file 14.00 KB Preview | Download
BIOMD0000000219.png Auto-generated Reaction graph (PNG) 16.54 KB Preview | Download
BIOMD0000000219.xpp Auto-generated XPP file 9.39 KB Preview | Download
BIOMD0000000219.pdf Auto-generated PDF file 218.89 KB Preview | Download
BIOMD0000000219.vcml Auto-generated VCML file 61.68 KB Preview | Download
BIOMD0000000219_manual.png Manually generated Reaction graph (PNG) 16.54 KB Preview | Download
BIOMD0000000219-biopax3.owl Auto-generated BioPAX (Level 3) 46.34 KB Preview | Download
BIOMD0000000219-biopax2.owl Auto-generated BioPAX (Level 2) 32.39 KB Preview | Download
BIOMD0000000219.svg Auto-generated Reaction graph (SVG) 34.68 KB Preview | Download
BIOMD0000000219.sci Auto-generated Scilab file 159.00 bytes Preview | Download
BIOMD0000000219_urn.xml Auto-generated SBML file with URNs 63.20 KB Preview | Download

  • Model originally submitted by : Indira Ghosh
  • Submitted: 29-Sep-2006 23:48:15
  • Last Modified: 20-Dec-2010 09:46:24
Revisions
  • Version: 2 public model Download this version
    • Submitted on: 20-Dec-2010 09:46:24
    • Submitted by: Indira Ghosh
    • With comment: Current version of Singh2006_TCA_mtu_model1
  • Version: 1 public model Download this version
    • Submitted on: 29-Sep-2006 23:48:15
    • Submitted by: Indira Ghosh
    • With comment: Original import of Singh_Ghosh2006_TCA_mtu_model1
Curator's comment:
(added: 07 Jul 2009, 14:51:16, updated: 07 Jul 2009, 14:51:16)
This model corresponds to the Mycobacterium tuberculosis model1 (i.e. model with KDH activity) reported in the publication. Steady state fluxes reported in Table 4 - Column 2 of the reference publication is reproduced here.